Skip to main content
LITTLE GREEN PHARMA LTD logo

LITTLE GREEN PHARMA LTD — Investor Relations & Filings

Ticker · LGP ISIN · AU0000074924 ASX Manufacturing
Open in API
Filings indexed 454 across all filing types
Latest filing 2022-06-30 Regulatory Filings
Country AU Australia
Listing ASX LGP

About LITTLE GREEN PHARMA LTD

https://www.littlegreenpharma.com/

Little Green Pharma Ltd is a vertically integrated medicinal cannabis company focused on the cultivation, production, and distribution of pharmaceutical-grade cannabis medicines. The company operates advanced cultivation and manufacturing facilities, producing a diverse range of products including oils and dried flower. Adhering to Good Manufacturing Practice (GMP) standards, it ensures product consistency and safety across its entire supply chain, from genetics and breeding to final delivery. Little Green Pharma serves both domestic and international markets, maintaining a significant presence in Europe, including Germany and the United Kingdom. The company is committed to advancing clinical research and development to support the therapeutic use of cannabis for various medical conditions, focusing on patient-centric care and high-quality delivery systems.

Recent filings

Filing Released Lang Actions
Annual Report to shareholders 78 pages 2.8MB
Regulatory Filings
2022-06-30 English
Corporate Governance Statement and Appendix 4G 32 pages 1.0MB
Governance Information Classification · 100% confidence The document is titled 'Corporate Governance Statement' and extensively discusses the company's governance practices, board roles, responsibilities, composition, diversity policies, and management oversight. It references compliance with ASX Corporate Governance Principles and includes detailed descriptions of governance structures and policies. There is no indication of financial statements, audit results, earnings data, or other financial performance metrics. The content aligns with governance information rather than financial reporting or announcements. Therefore, the document fits the category of Governance Information (CGR). The document length (15,000 characters) and detailed content confirm it is a full governance report, not a brief announcement or summary.
2022-06-30 English
Company Update Presentation 23 pages 2.9MB
Investor Presentation Classification · 95% confidence The document is a detailed presentation about Little Green Pharma Ltd, including corporate overview, investment highlights, business model, growth strategy, market leadership, sales track record, and research initiatives. It contains forward-looking statements, disclaimers, and extensive business and financial information but does not present formal financial statements or regulatory filings. The content is structured as a presentation aimed at investors, focusing on company strategy, market position, and growth prospects. There is no indication that this is an official annual or interim report, audit report, earnings release, or regulatory filing. The presence of slides, charts, and strategic information aligns with an Investor Presentation (IP). The document length (15,000 characters) and detailed content support this classification with high confidence.
2022-06-05 English
Preliminary Final Report 20 pages 767.9KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Appendix 4E' and covers financial results for the 9 month period ended 31 March 2022. It contains detailed unaudited financial statements including consolidated statement of financial position, profit and loss, changes in equity, and cash flows. It also includes a review of operations, key achievements, and notes on accounting standards and ownership changes. The document is prepared in accordance with Australian Accounting Standards and is submitted to the ASX under Listing Rule 4.3A, which typically relates to interim or quarterly financial reports. The presence of comprehensive financial data and analysis for a period shorter than a full fiscal year (9 months) confirms this is an Interim / Quarterly Report. It is not a full Annual Report (10-K), nor a brief announcement or certification. Therefore, the correct classification is Interim / Quarterly Report (IR). 9M 2022
2022-05-30 English
Exclusive supply contract for new high-THC strain in Germany 3 pages 247.9KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 19 May 2022, detailing a new high-volume take-or-pay contract between Little Green Pharma and Four 20 Pharma in Germany. It focuses on the terms of the contract, the strategic significance, and expected deliveries. There are no financial statements, quarterly or annual results, or detailed financial analysis included. The content is about a capital or financing update related to a significant contract agreement impacting the company's revenue and supply chain. The document length is 7324 characters, which is substantive but does not contain financial report data. Therefore, it fits best under Capital/Financing Update (CAP).
2022-05-18 English
Application for quotation of securities - LGP 6 pages 28.5KB
Share Issue/Capital Change Classification · 95% confidence The document is an application for quotation of securities on the ASX by Little Green Pharma Ltd. It details the issuance of additional ordinary fully paid shares as consideration for services, the number of securities to be quoted, and compliance with listing rules. There is no financial performance data, earnings information, or management discussion. The document is an announcement related to capital changes, specifically the issuance and quotation of new shares. This fits the category of Share Issue/Capital Change (SHA). The document length is over 6,000 characters and contains detailed information about the share issuance, not just a brief notice or a report publication announcement.
2022-05-08 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.